David Cameron says that we have reached a "tipping point" where the combination of new Alzheimer's treatments and new biotech and pharmaceutical companies could result in someone alive today having their Alzheimer's condition 'reversed.' He speaks at a Bloomberg.com subscriber event in London. (Source: Bloomberg)
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
